Application of "metal-water generating" theory in malignant pleural effusion of lung cancer

Li Xiaomei; Shen Yang; Yang Jie; Wei Yue; Sun Tao

doi:10.3969/j.issn.2095-6606.2021.02.013

Suggestions

您当前的位置：

首页 >

文章列表页 >

Application of "metal-water generating" theory in malignant pleural effusion of lung cancer

Previous: Application of Zhuling Decoction(猪苓汤)in Treatment of Cancer Edema

Next: Therapeutic method of tonifying Qi and activating blood for Raynaud's syndrome: a proven case

Application of "metal-water generating" theory in malignant pleural effusion of lung cancer
1.Beijing University of Chinese Medicine, Beijing 100020
2.Dongzhimen Hospital, Beijing University of Chinese Medicine
3.Dongfang Hospital of Beijing University of Chinese Medicine
DOI：10.3969/j.issn.2095-6606.2021.02.013

扫描看全文

Li Xiaomei, Shen Yang, Yang Jie, et al. Application of "metal-water generating" theory in malignant pleural effusion of lung cancer[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.2095-6606.2021.02.013
DOI：

Li Xiaomei, Shen Yang, Yang Jie, et al. Application of "metal-water generating" theory in malignant pleural effusion of lung cancer[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.2095-6606.2021.02.013 DOI：

摘要

肺癌是临床常见的恶性肿瘤之一，肺癌患者在疾病发展中合并恶性胸腔积液（maligant pleural effusion，MPE）往往预后不良。“金水相生”又称“肺肾相生”“肺肾同源”，肺肾阴阳相资，共主呼吸，协调津液输布与代谢，经络相连，在生理方面密切相关。肺肾亏虚是肺癌MPE重要的发病因素。临床治疗手段加重肺肾亏虚。肺癌MPE治疗强调肺肾同治，金水相生理论可指导治疗肺癌MPE的遣药组方，并结合临床典型病案加以阐述。

Abstract

The lung cancer is one of the most common malignant tumors in clinical practice. The prognosis of the lung cancer patients with malignant pleural effusion (MPE) is often poor. "Metal-water generation" is also known as "Mutual Generation between the Lung and Kidney" and "Lung and Kidney Homogeny". The lung and kidney are closely related as they are both involved in breathing, coordination of fluid distribution and metabolism and they are connected by meridians. Deficiency of the lung and kidney is an important pathogenic factor of MPE in the lung cancer. Clinical treatment often aggravates the deficiency of the lung and kidney. The treatment of lung cancer MPE emphasizes the treatment of both the lung and kidney. The theory of metal-water generating can guide the prescription and medication of lung cancer MPE, which is expounded in combination with the typical clinical records.

关键词

肺癌恶性胸腔积液肺肾亏虚金水相生

Keywords

lung cancermalignant pleural effusiondeficiency of the lung and kidneymetal-water generating

references

DE GROOT P M, WU C C, CARTER B W, et al. The epidemiology of lung cancer[J]. Transl Lung Cancer Res, 2018, 7(3): 220-233.

BRADSHAW M, MANSFIELD A, PEIKERT T. The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion[J]. Current Oncology Reports, 2013, 15(3): 207-216.

ROBERTS M E, NEVILLE E, BERRISFORD R G, et al. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010[J]. Thorax, 2010, 65(Suppl 2): ii32-ii40.

张冰玉, 金润铭. 恶性胸腔积液诊断及治疗[J]. 中国实用儿科杂志, 2017, 32(3): 178-181.

胡成平.2014恶性胸腔积液诊断和治疗专家共识要点解读[J]. 中国实用内科杂志, 2014, 34(8): 765-766.

汪文琦. 杂证会心录[M]. 侯如艳，校注. 北京: 中国医药科技出版社, 2011: 28-29.

雷丰. 时病论[M]. 杨梅香, 郑金生，校点. 福州: 福建科学技术出版社, 2010: 80.

陈士铎. 石室秘录[M]. 张灿岬，点校. 北京: 中国中医药出版社, 1991: 277.

林佩琴. 类证治裁[M]. 孙玉信, 朱平生，主校. 上海: 第二军医大学出版社, 2008: 97.

李中梓. 医宗必读[M]. 王卫, 张艳军, 徐立, 等，点校. 天津: 天津科学技术出版社, 1999.

张朝宁, 李金田.“肺肾相关”理论探讨及现代研究进展[J]. 新中医, 2016, 48(1): 200-201.

秦越人. 难经[M]. 北京: 科学文献技术出版社, 1996: 17.

赵敏, 周艳艳, 陈会敏, 等.“肺肾相关”的理论探讨[J]. 湖北中医药大学学报, 2013, 15(6): 38-39.

金银珠, 沈影, 韩凤娟.“阳化气，阴成形”：卵巢癌的中医证治[J]. 天津中医药大学学报, 2020, 39(4): 403-406.

何丰华, 刘玉姿, 陈志刚, 等. 解建国教授治疗肺癌恶性胸水经验介绍[J]. 新中医, 2013, 45(10): 163-164.

刘海龙, 王钢, 王佳, 等. 基于“金水相生”从“肺肾同治”论治干燥综合征理论探析[J]. 中医药信息, 2019, 36(4): 39-42.

李中梓. 内经知要[M]. 陆鸿元, 包来发，校注. 北京: 中国中医药出版社, 1994: 33.

张介宾. 景岳全书[M]. 夏之秋，校注. 北京: 中国中医药出版社, 1994.

杨晨光, 王松海, 许鹏. 从命门水火论治恶性胸腔积液[J]. 陕西中医, 2019, 40(2): 247-249.

于福源, 赵辰, 张倩. 胃肠道肿瘤手术后中医病机[J]. 中国社区医师, 2020, 36(26): 115-116.

霍志刚, 马小莉, 李建设, 等. 肺癌恶性胸腔积液中医证型分布的相关性研究[J]. 环球中医药, 2015, 8(11): 1346-1349.

席玉棚, 杨子禛, 金志超, 等. 花宝金辨治肺癌咳嗽八法[J]. 山东中医药大学学报, 2019, 43(3): 297-300.

袁旭, 龚爱琴, 李敬瑜, 等. 范忠泽“扶正法”治疗肺癌经验概述[J]. 浙江中医杂志, 2019, 54(8): 556-557.

杨建平. 百合固金汤治疗肺癌晚期并发胸水的临床观察[J]. 光明中医, 2018, 33(21): 3164-3166.

汪昂. 医方集解[M]. 鲍玉琴, 杨德利，校注. 北京: 中国中医药出版社, 1997: 23.

陈代斌. 金水六君煎临床应用浅探[J]. 实用中医药杂志, 2005, (9): 573.

龚居中. 痰火点雪[M]. 傅国治, 王庆文，点校. 北京: 人民卫生出版社, 1996: 4.

孙建立, 刘嘉湘. 刘嘉湘辨治肺癌胸水经验[J]. 上海中医药杂志, 2011, 45(1): 13-14.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Dong's Extraordinary Points in the Treatment of Advanced Lung Cancer Pain for Two Cases

New Understanding of "Cancer Toxic’s Dissemination and Setting Down" Theory and ItsApplication in the Prevention and Treatment of Recurrence and Metastasis of Lung Cancer

LIN Hongsheng's Clinical Experience in the Treatment of Lung Cancer with the Method of Softening Hardness and Dissipating Mass

Exploration on connotation of Zhigancao Decoction formula syndrome from the perspective of modern pathophysiology and severe cases of critical care and its clinical efficacy on cardioversion, maintenance of sinus rhythm, hemostasis, increasing platelets count, and tonifying deficiency

Experience of LIU Wei-Sheng in Treating Yin-deficiency with Toxin and Heat Type of Lung Cancer

Related Author

No data

Related Institution

Department of Oncology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

The First Affiliated Hospital of Hunan University of Chinese Medicine

Hunan University of Chinese Medicine

Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences

China Academy of Chinese Medical Sciences

⁰